Veoza, also known as fezolinetant, is prescription-only and will be available privately from January
A “gamechanging” drug that prevents hot flushes and could benefit hundreds of thousands of women has been approved for use in the UK.
The green light for Veoza, also known as fezolinetant, comes after the US regulator, the Food and Drug Administration, authorised it for use in America in May.
More Stories
Brisk walking linked to lower risk of heart rhythm problems, study finds
Revealed: Chinese researchers can access half a million UK GP records
Opt out: how to protect your data and privacy if you own a Tesla